New antibody therapy shows promise for advanced pediatric brain cancer - Massachusetts General Hospital

The new agent, called TB-403, was well tolerated and induced stabilization of the disease in some medulloblastoma patients.

Blocking PlGF, unlike other cancer-related pathways, was safe in humans and thus was a particularly promising strategy in the pediatric population. Rakesh K. Jain, PhDDirector, E.L. Steele Laborator… [+6120 chars]

full article...